MNCLHD

MNCLHD

Friday, December 08, 2023

Congratulations to MNCLHD who have published!


 Al-Timimi, Z., J. Huang-Lung, L. Keay, P. Healey, E. Yang and H. Dunn (2023). "A Systematic Review of Glaucoma Diagnosis in Prevalence Studies and Quality of Reporting." J Glaucoma. Jun 27. doi: 10.1097/IJG.0000000000002248. Online ahead of print.

Antonarakis, E. S., S. H. Park, J. C. Goh, S. J. Shin, J. L. Lee, N. Mehra, R. McDermott, N. Sala-Gonzalez, P. C. Fong, R. Greil, M. Retz, J. P. Sade, P. Yanez, Y. H. Huang, S. D. Begbie, R. A. Gafanov, M. De Santis, E. Rosenbaum, M. P. Kolinsky, F. Rey, K. Y. Chiu, G. Roubaud, G. Kramer, M. Sumitomo, F. Massari, H. Suzuki, P. Qiu, J. Zhang, J. Kim, C. H. Poehlein and E. Y. Yu (2023). "Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial." J Clin Oncol: Jco2300233

Brown, K. and M. Clarke (2023). "First Nations women's health 2023." The Australian & New Zealand journal of obstetrics & gynaecology 63(3): 275-277.

Friedlander, M., L. Mileshkin, J. Lombard, S. Frentzas, B. Gao, M. Wilson, T. Meniawy, S. Baron-Hay, K. Briscoe, N. McCarthy, C. Fountzilas, A. Cervantes, R. Ge, J. Wu and A. Spira (2023). "Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial." British Journal of Cancer 129(5): 797-810.

Gandy, G., P. Y. Yip, A. Tognela, F. Hayat, W. Fox and P. S. Kok (2023). "Outcomes of extensive stage extrapulmonary small cell cancer." Internal Medicine Journal 53(9): 1556-1563.

Gleadhill, C., K. Dooley, S. J. Kamper, N. Manvell, M. Corrigan, A. Cashin, N. Birchill, B. Donald, M. Leyland, A. Delbridge, C. Barnett, D. Renfrew, S. Lamond, C. E. Boettcher, L. Chambers, T. Maude, J. Davis, S. Hodgson, A. Makaroff, J. B. Wallace, K. Kotrick, N. Mullen, R. Gallagher, S. Zelinski, T. Watson, S. Davidson, P. Viana Da Silva, B. Mahon, C. Delore, J. Manvell, B. Gibbs, C. Hook, C. Stoddard, E. Meers, M. Byrne, T. Schneider, K. Bolsewicz and C. M. Williams (2023). "What does high value care for musculoskeletal conditions mean and how do you apply it in practice? A consensus statement from a research network of physiotherapists in New South Wales, Australia." BMJ open 13(6): e071489.

Hong, A. M., A. Sundaram, G. Perianayagam, H. Lo, A. Lawless, D. Zhou, J. McDonough, S. R. Thompson, F. Maclean, E. A. Connolly, D. Coker, J. Mar, S. Lazarakis and A. Johnston (2023). "Surgery at specialised sarcoma centres improves patient outcomes - A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party." Eur J Surg Oncol.

Huijbers, J. C. J., P. Coenen, G. L. B. Burchell, M. W. Coppieters, I. H. M. Steenhuis, J. H. Van Dieen, B. W. Koes, D. H. R. Kempen, J. R. Anema, I. Kingma, L. Voogt, C. M. Williams, J. M. Van Dongen, H. P. Van der Ploeg, R. W. J. G. Ostelo and G. G. M. Scholten-Peeters (2023). "The (cost-)effectiveness of combined lifestyle interventions for people with persistent low-back pain who are overweight or obese: A systematic review." Musculoskeletal science & practice 65: 102770. 

Lavis, H., P. van Vliet and M. Tavener (2023). "Lessons Learnt by an Experienced Clinician-Novice Researcher Throughout the Process of Qualitative Research Interviewing." The Qualitative Report 28(6): 1665-1679.

Shakespeare, T. P., S. Z. L. Yap, M. Hsieh, A. R. M. Tahir and S. Armstrong (2023). "Prostate-specific membrane antigen positron emission tomography detected local failure after post-prostatectomy radiation therapy: Low rates of out-of-field recurrence validates current Australian prostate bed contouring guidelines." Journal of Medical Imaging & Radiation Oncology 67(6): 662-667.

Sidhu, V. S., T. L. Kelly, N. Pratt, S. E. Graves, R. Buchbinder, S. Adie, K. Cashman, I. N. Ackerman, D. Bastiras, R. Brighton, A. W. R. Burns, B. H. Chong, O. Clavisi, M. Cripps, M. Dekkers, R. de Steiger, M. Dixon, A. Ellis, E. C. Griffith, D. Hale, A. Hansen, A. Harris, R. Hau, M. Horsley, D. James, O. Khorshid, L. Kuo, P. L. Lewis, D. Lieu, M. Lorimer, S. J. MacDessi, P. McCombe, C. McDougall, J. Mulford, J. M. Naylor, R. S. Page, J. Radovanovic, M. Solomon, R. Sorial, P. Summersell, P. Tran, W. L. Walter, S. Webb, C. Wilson, D. Wysocki and I. A. Harris (2023). "Effect of Aspirin vs Enoxaparin on 90-Day Mortality in Patients Undergoing Hip or Knee Arthroplasty: A Secondary Analysis of the CRISTAL Cluster Randomized Trial." JAMA Netw Open 6(6): e2317838.

Taylor, R., D. Sullivan, P. Reeves, N. Kerr, A. Sawyer, E. Schwartzkoff, A. Bailey, C. Williams and A. Hure (2023). "A Scoping Review of Economic Evaluations to Inform the Reorientation of Preventive Health Services in Australia." Int J Environ Res Public Health 20(12).

Treloar, C., K. Beadman, M. Beadman, K. A. Smith, J. Christian, A. C. Jackson, B. Tyson, C. Anderson, L. Smyth, M. Walker, J. Heslop, G. Gahan, V. Tawil, F. Sheaves, L. Maher, J. Page, D. Tilley, A. Ryan, K. Grant, B. Donovan, A. Stevens, T. Slattery, K. Pearce, F. John-Leader, A. Walden, J. Lenton, M. Crowley and E. Cama (2023). "Evaluating a complex health promotion program to reduce hepatitis C among Aboriginal and Torres Strait Islander peoples in New South Wales, Australia: the Deadly Liver Mob." Harm Reduction Journal 20(1): 153.

The Library at MNCLHD collects all papers published all staff members. If you have published this year and haven't seen your paper mentioned in a blog or newsletter please let the library know.

Promoting Kidney Health in People with Type 2 Diabetes

This two-part series by Fiona Murphy and Gobnait Byrne delves into the escalating incidence of chronic kidney disease (CKD), intricately linked to the risk factors shared with type 2 diabetes.

Promoting kidney health in people with type 2 diabetes: part 1 - British Journal of Nursing V.32(18), pages 874-880. Part 2 V.32(20, pages 964-971.

The articles emphasize the critical role of nurses in employing primary, secondary, and tertiary prevention strategies to mitigate the impact of these interconnected chronic conditions. Part 1 focuses on the significance of primary prevention, while Part 2 delves into secondary and tertiary prevention measures relevant to individuals with type 2 diabetes.

In Part 1, the articles explore the strong interconnection between CKD and type 2 diabetes, underscoring the importance of promoting kidney health. The discussion begins by describing CKD and type 2 diabetes, addressing their prevalence, and acknowledging the triple threat when combined with cardiovascular disease. The article advocates for primary preventive measures and provides practical examples to guide nurses in primary, community, secondary, and hospital care settings.

The need for mindfulness regarding the interrelationship between these long-term conditions is emphasized. Nurses are encouraged to take every opportunity to educate and empower individuals with type 2 diabetes, facilitating informed and active choices for their health outcomes and life goals. Part 1 discusses the relevance of primary prevention in promoting kidney health and highlights the strong interrelationship with cardiovascular concerns.

National and international best practice guidelines are cited, emphasizing the importance of promoting healthy lifestyles, including smoking cessation, alcohol reduction, maintaining a healthy diet, weight management, physical activity, and exercise. These guidelines are pertinent not only to promoting kidney health but also to diabetic and heart health.

Part 2 is previewed, promising a further exploration of promoting kidney health using secondary and tertiary preventive measures in individuals with type 2 diabetes. 

In Part 2, the article addresses the importance of timely diagnosis through screening for CKD, particularly in the context of diabetes-related CKD in low- and middle-income countries. Secondary prevention's role in reducing the estimated glomerular filtration rate decline is highlighted, emphasizing early referral to nephrology services.

The article continues to discuss the relevance of promoting kidney health using secondary and tertiary preventive measures in individuals with type 2 diabetes. Nurses are urged to screen for CKD, address major causes, and provide interventions for healthy lifestyles, obesity, and psychosocial care needs. Tertiary prevention is recognized as vital for enabling individuals to live well with these conditions, utilizing DSMES programs and pharmacological therapies to enhance quality of life and prevent complications.

In summary, this two-part series provides a comprehensive guide for nurses and healthcare professionals to navigate the complex interplay between CKD, type 2 diabetes, and cardiovascular disease. By focusing on prevention strategies at various levels, the articles underscore the importance of a holistic and proactive approach when managing these interconnected chronic conditions.

Contact the library for a copy of these articles.